The diverse range of exciting research underway across the Northern Health Precinct was profiled during a recent showcase, highlighting the impact of research throughout Northern Sydney Local Health District. The event directed the spotlight to a range of disciplines driving research including nursing, midwifery, and pharmacy, as well as allied health and public health. Precinct Academic Director P.....
Read more

Researchers at the Kolling Institute have taken an important step towards the development of safer, non-addictive pain medications by increasing our understanding of spinal cord pain signalling. This valuable progress has been recognised internationally with publication in the Journal of Physiology, a leading scientific journal. The findings follow the latest figures indicating more than 20 per cen.....
Read more

Ambitious leadership, functional wellbeing and a passion for collaboration An international healthcare destination celebrated for its collaborative spirits and dedication to human health and wellbeing. This is Professor Jim Elliott’s vision for how the collaboration between the Kolling Institute, the Faculty of Medicine and Health and the Northern Sydney Local Health District will evolve. Highly re.....
Read more

New research by a team from the Kolling Institute has found the best treatment for chronic low back pain doesn’t just focus on the physical, but combines physiotherapy treatments with those focusing on the mind. The study, involving Emma Ho, Professor Manuela Ferreira and Lingxiao Chen, analysed evidence from almost 100 trials worldwide involving over 13,000 patients. It found a combination of phys.....
Read more

With large numbers of people across the community looking for effective and lasting ways to treat pain, our researchers at the Kolling Institute are driving nationally significant projects to reduce a reliance on opioid medication and promote proven alternative options. The research by our team from the Pain Management Research Centre follows the latest figures which indicate around 20 per cent of .....
Read more

Kolling researchers have taken out a highly-competitive, national award for an innovative program helping people get back to work after injury. Professor Michael Nicholas and Dr Manasi Mittinty from the Pain Management Research Centre were part of a team which received a National Safety Award of Excellence for their initiative targeting injured workers. The program was trialled with staff from Aust.....
Read more

Congratulations to Kolling Institute researcher Dr Manasi Mittinty who has been selected for the Advanced Global Clinical Scholar Research training at Harvard Medical School. Dr Mittinty is a medical trained researcher with the Pain Management and Research Centre and a University of Sydney lecturer. She has a keen interest in translation research and the connections between musculoskeletal conditio.....
Read more

Researchers from the Kolling Institute will strengthen their expertise in the management of low back pain following a significant funding announcement by the Federal Government. Health minister Greg Hunt revealed the latest round of National Health and Medical Research Investigator Grants, which will see $2.5 million directed to a five-year program of research led by Professor Manuela Ferreira to i.....
Read more

The John Walsh Centre for Rehabilitation Research has been awarded close to $10 million to help improve the lives of those living with injury-related disability. The funding has been granted by the state’s compensation agencies icare NSW and the State Insurance Regulatory Authority, continuing a 20 year research partnership. icare NSW Managing Director and CEO Richard Harding said the research was .....
Read more

The Neuroscience and Pain Research Showcase provided a timely opportunity to demonstrate the breadth of expertise across this priority research area at the Kolling. Co-ordinated by Professors Paul Glare and Lisa Harvey, the online event attracted more than 250 people. A diverse range of presentations focused on the cutting-edge research targeting mitochondrial disease, psychiatric disorders, spinal.....
Read more